[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "786 977 3380", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 76, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8606, "open": 0.85, "dayLow": 0.85, "dayHigh": 1.13, "regularMarketPreviousClose": 0.8606, "regularMarketOpen": 0.85, "regularMarketDayLow": 0.85, "regularMarketDayHigh": 1.13, "payoutRatio": 0.0, "beta": 0.539, "forwardPE": -1.3464788, "volume": 7598462, "regularMarketVolume": 7598462, "averageVolume": 5838001, "averageVolume10days": 25256400, "averageDailyVolume10Day": 25256400, "bid": 0.907, "ask": 0.9967, "bidSize": 3, "askSize": 3, "marketCap": 2827714, "fiftyTwoWeekLow": 0.797, "fiftyTwoWeekHigh": 7.5, "fiftyDayAverage": 1.26974, "twoHundredDayAverage": 2.907455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4594579, "profitMargins": 0.0, "floatShares": 2476019, "sharesOutstanding": 2957860, "sharesShort": 44258, "sharesShortPriorMonth": 14425, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.015, "heldPercentInsiders": 0.0402, "heldPercentInstitutions": 0.13909, "shortRatio": 0.01, "shortPercentOfFloat": 0.0162, "impliedSharesOutstanding": 2957860, "bookValue": 10.603, "priceToBook": 0.090163164, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13904584, "trailingEps": -12.69, "forwardEps": -0.71, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": 0.338, "52WeekChange": -0.8705263, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 0.956, "recommendationKey": "none", "totalCash": 6922729, "totalCashPerShare": 2.559, "ebitda": -13600933, "totalDebt": 0, "quickRatio": 6.182, "currentRatio": 6.58, "returnOnAssets": -0.42228, "returnOnEquity": -0.72835, "freeCashflow": -9000477, "operatingCashflow": -13923438, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 11.085287, "regularMarketPrice": 0.956, "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "postMarketChangePercent": -2.71966, "postMarketPrice": 0.93, "postMarketChange": -0.026, "regularMarketChange": 0.095399976, "regularMarketDayRange": "0.85 - 1.13", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5838001, "fiftyTwoWeekLowChange": 0.15899998, "fiftyTwoWeekLowChangePercent": 0.19949809, "fiftyTwoWeekRange": "0.797 - 7.5", "fiftyTwoWeekHighChange": -6.544, "fiftyTwoWeekHighChangePercent": -0.8725334, "fiftyTwoWeekChangePercent": -87.05263, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755374400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.69, "epsForward": -0.71, "fiftyDayAverageChange": -0.31374002, "fiftyDayAverageChangePercent": -0.24708997, "twoHundredDayAverageChange": -1.951455, "twoHundredDayAverageChangePercent": -0.6711901, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "firstTradeDateMilliseconds": 1631712600000, "hasPrePostMarketData": true, "corporateActions": [], "postMarketTime": 1747439910, "regularMarketTime": 1747425601, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]